CBLL1 and colorectal carcinoma: However, when we analysed the expression levels of CBLL1 considering only CMS2 CRC patients (Figure 6b), and these patients were grouped into high and low CBLL1 expression (Figure 6b, left panel), the Kaplan–Meier analysis of CMS2 showed the opposite result (Figure 6b, right panel).